PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsAlkem Laboratories
Alkem Laboratories
Alkem Laboratories Limited is an Indian multinational pharmaceutical company headquartered in Mumbai, Maharashtra, India that manufactures and sells pharmaceutical generics, formulations and nutraceuticals in India and globally.
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Amlodipine besylateAmlodipine besylate2009-05-04
—
Amlodipine olmesartan medoxomilAmlodipine besylate, Olmesartan medoxomil2017-08-14
—
AmphetamineAmphetamine2020-10-272024-2038
Narcolepsy
,
Attention deficit disorder with hyperactivity
ApremilastApremilast2021-09-212028-2034
Psoriatic arthritis,
Psoriasis
AripiprazoleAripiprazole2019-02-212023-2034
Schizophrenia,
Bipolar disorder,
Schizophrenia spectrum and other psychotic disorders
AtorvastatinAtorvastatin2018-12-212037
Hypercholesterolemia,
Coronary artery disease,
Hypertriglyceridemia,
Hyperlipoproteinemias,
Hypertension,
Variant angina pectoris,
Familial combined hyperlipidemia,
Hyperlipoproteinemia type ii
AzathioprineAzathioprine2020-03-27
Ulcerative colitis,
Rheumatoid arthritis,
Multiple sclerosis,
Crohn disease,
Thrombocytopenic purpura idiopathic,
Systemic lupus erythematosus,
Graft rejection
AzelastineAzelastine2017-08-182023-2028
Allergic conjunctivitis,
Allergic rhinitis perennial,
Vasomotor rhinitis
Brompheniramine maleate, pseudoephedrine dextromethorphanBrompheniramine, Dextromethorphan, Pseudoephedrine2020-07-142023-2040
Atrial fibrillation,
Atrial flutter,
Cardiac arrhythmias,
Cough,
Neurobehavioral manifestations,
Sinusitis,
Asthma,
Common cold,
Allergic rhinitis perennial,
Urticaria,
Vasomotor rhinitis,
Whooping cough,
Bronchitis,
Pharyngitis,
Laryngitis,
Postoperative complications,
Pain,
Vomiting,
Nausea,
Anaphylaxis,
Allergic conjunctivitis,
Motion sickness,
Tobacco use disorder,
Attention deficit disorder with hyperactivity,
Depressive disorder
Buprenorphine naloxoneBuprenorphine, Naloxone2021-06-152024-2038
Septic shock,
Pain,
Opioid-related disorders,
Heroin dependence,
Respiration disorders
CapecitabineCapecitabine2017-11-24
Colorectal neoplasms,
Breast neoplasms,
Stomach neoplasms,
Colonic neoplasms
CefdinirCefdinir2021-02-19
Sinusitis,
Otitis media,
Bacterial infections,
Bacterial skin diseases,
Escherichia coli infections,
Bronchitis,
Streptococcal infections,
Tonsillitis,
Bacterial pneumonia,
Staphylococcal infections,
Proteus infections,
Klebsiella infections,
Haemophilus infections,
Moraxellaceae infections
CefiximeCefixime2018-10-092028
Urinary tract infections,
Otitis media,
Bacterial infections,
Gonorrhea,
Bacterial skin diseases,
Escherichia coli infections,
Soft tissue infections,
Bronchitis,
Streptococcal infections,
Bacterial pneumonia,
Staphylococcal infections,
Proteus infections,
Klebsiella infections,
Haemophilus infections,
Moraxellaceae infections
1
2
3
4
5
6
...
9
>
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Mycophenolate mofetil
autoimmune diseases
Mycophenolic acid
autoimmune diseases
Mycophenolate sodium
autoimmune diseases
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use